Published in Semin Reprod Med on January 01, 2008
Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study. Clin Exp Reprod Med (2011) 2.13
Cholesterol screening for women: who is "at-risk"? J Womens Health (Larchmt) (2013) 2.02
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update (2010) 1.45
Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology (2009) 1.32
The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol (2011) 1.20
Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod (2010) 1.13
Lifestyle interventions for hypertension and dyslipidemia among women of reproductive age. Prev Chronic Dis (2011) 1.08
Animal models of the polycystic ovary syndrome phenotype. Steroids (2013) 0.96
Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin Reprod Med (2011) 0.96
Stress and Androgen Activity During Fetal Development. Endocrinology (2015) 0.91
Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol (2013) 0.87
Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia. Iran J Reprod Med (2015) 0.87
Role of nuclear receptors in blastocyst implantation. Semin Cell Dev Biol (2013) 0.87
Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am (2011) 0.85
Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study. Reprod Biol Endocrinol (2010) 0.81
Statins in the treatment of polycystic ovary syndrome. Semin Reprod Med (2008) 0.80
The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndrome. Saudi Med J (2015) 0.78
Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179. J Assist Reprod Genet (2012) 0.77
Obstetric and Neonatal Outcome in PCOS with Gestational Diabetes Mellitus. J Family Reprod Health (2014) 0.76
Evaluation of follicular synchronization caused by estrogen administration and its reproductive outcome. PLoS One (2015) 0.75
Reduced protein C Global assay level in infertile women prior to IVF-ET treatment. J Assist Reprod Genet (2013) 0.75
Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome. J Transl Med (2015) 0.75
An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials. BMJ Open (2015) 0.75
Progesterone response in neonatal endometrium is key to future reproductive health in adolescents. Womens Health (Lond Engl) (2016) 0.75
Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome. J Perinatol (2012) 0.75
PCOSDB: PolyCystic Ovary Syndrome Database for manually curated disease associated genes. Bioinformation (2016) 0.75
Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome. J Nephropathol (2016) 0.75
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation. Diabetes Care (2013) 0.75
Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran J Reprod Med (2012) 0.75
Trends in serum lipids and hypertension prevalence among non-pregnant reproductive-age women: United States National Health and Nutrition Examination Survey 1999-2008. Matern Child Health J (2013) 0.75
Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer. Sci Rep (2017) 0.75
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet (2007) 3.36
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet (2005) 2.73
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab (2003) 2.26
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod (2007) 2.11
The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev (2006) 1.75
Primary ovarian insufficiency. Lancet (2010) 1.67
The impact of ovarian stimulation for IVF on the developing embryo. Reproduction (2010) 1.63
Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab (2007) 1.61
Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab (2004) 1.61
The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci (2008) 1.50
Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol (2004) 1.46
Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One (2010) 1.41
Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome. Hum Reprod (2013) 1.40
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab (2008) 1.39
Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol (2008) 1.38
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab (2004) 1.37
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod (2004) 1.32
A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril (2002) 1.27
Balancing the strengths of systematic and narrative reviews. Hum Reprod Update (2004) 1.24
New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv (2002) 1.21
Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One (2010) 1.20
What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update (2013) 1.14
A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab (2007) 1.10
Renaming PCOS--a two-state solution. J Clin Endocrinol Metab (2013) 1.08
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
Tackling burden in ART: an integrated approach for medical staff. Hum Reprod (2012) 1.07
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril (2003) 1.06
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril (2002) 1.02
High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod (2003) 1.01
Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod (2009) 1.01
The preconception Mediterranean dietary pattern in couples undergoing in vitro fertilization/intracytoplasmic sperm injection treatment increases the chance of pregnancy. Fertil Steril (2010) 1.00
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
Low folate in seminal plasma is associated with increased sperm DNA damage. Fertil Steril (2008) 0.98
Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update (2003) 0.96
IVF outcomes are associated with biomarkers of the homocysteine pathway in monofollicular fluid. Hum Reprod (2009) 0.96
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril (2011) 0.95
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online (2011) 0.95
Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril (2009) 0.94
Polycystic ovary syndrome. BMJ (2011) 0.94
Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation. Hum Reprod (2008) 0.94
Preconception folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertil Steril (2007) 0.93
IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction. Reprod Biomed Online (2003) 0.93
Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril (2002) 0.93
Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab (2010) 0.92
Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. J Clin Endocrinol Metab (2011) 0.92
Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril (2002) 0.91
Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev (2012) 0.91
Endometrial stromal cells of women with recurrent miscarriage fail to discriminate between high- and low-quality human embryos. PLoS One (2012) 0.89
Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium. Hum Reprod Update (2013) 0.89
The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril (2011) 0.89
Human studies on genetics of the age at natural menopause: a systematic review. Hum Reprod Update (2010) 0.89
The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod (2010) 0.89
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril (2005) 0.89
Embryo implantation: biology, evaluation, and enhancement. Curr Opin Obstet Gynecol (2013) 0.89
In-vitro model systems for the study of human embryo-endometrium interactions. Reprod Biomed Online (2013) 0.88
Ovulation induction in normogonadotropic anovulation (PCOS). Best Pract Res Clin Endocrinol Metab (2006) 0.88
Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment. J Clin Endocrinol Metab (2011) 0.87
Contemporary pharmacological manipulation in assisted reproduction. Drugs (2004) 0.87
Review: in vitro models for the study of early human embryo-endometrium interactions. Reprod Sci (2009) 0.86
Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model. Fertil Steril (2011) 0.86
Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril (2007) 0.86
Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC Womens Health (2012) 0.85
Increased preconception omega-3 polyunsaturated fatty acid intake improves embryo morphology. Fertil Steril (2010) 0.85
Ovarian stimulation and embryo quality. Reprod Biomed Online (2009) 0.85
The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function. Hum Reprod Update (2013) 0.85
Copy number variants on the X chromosome in women with primary ovarian insufficiency. Fertil Steril (2011) 0.84
Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk. Menopause (2010) 0.84
Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype. J Clin Endocrinol Metab (2013) 0.84
Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors. PLoS One (2013) 0.84
Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Hum Reprod (2005) 0.84
Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI). Fertil Steril (2011) 0.84
The fate of the mosaic embryo: chromosomal constitution and development of Day 4, 5 and 8 human embryos. Hum Reprod (2010) 0.83
Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment. Eur J Endocrinol (2005) 0.83
Preimplantation genetic screening: the end of an affair? Hum Reprod (2008) 0.83
Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference? J Clin Endocrinol Metab (2010) 0.83
Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol (2011) 0.83
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertil Steril (2003) 0.83
Preimplantation aneuploidy screening: a research tool for now. Lancet (2007) 0.83
Cell lineage specific distribution of H3K27 trimethylation accumulation in an in vitro model for human implantation. PLoS One (2012) 0.82
Recurrent pre-clinical pregnancy loss is unlikely to be a 'cause' of unexplained infertility. Hum Reprod (2011) 0.81
Lipid profile of women with premature ovarian failure. Menopause (2008) 0.81
The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial. BMC Womens Health (2010) 0.81
Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online (2003) 0.81
FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur J Endocrinol (2002) 0.80
Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Reprod Sci (2007) 0.80
Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. Trends Endocrinol Metab (2005) 0.80
Cost-effectiveness of hysteroscopy screening for infertile women. Reprod Biomed Online (2013) 0.80
What role of estrogens in ovarian stimulation. Maturitas (2006) 0.79
Predictors of recovery of ovarian function during weight gain in anorexia nervosa. Fertil Steril (2007) 0.79
High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. Fertil Steril (2012) 0.79
The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol (2006) 0.77